Advertisement
OtherBehavioral Pharmacology

Enhancement of opioid antinociception by nicotinic ligands

Fernando Barreto de Moura and Jack Bergman
Journal of Pharmacology and Experimental Therapeutics January 13, 2021, JPET-AR-2020-000423; DOI: https://doi.org/10.1124/jpet.120.000423

Article Information

JPET-AR-2020-000423
DOI 
https://doi.org/10.1124/jpet.120.000423
PubMed 
33441370
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online January 13, 2021.
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Fernando Barreto de Moura1 and
  2. Jack Bergman2,*
  1. 1McLean Hospital/Harvard Medical School, United States of America
  2. 2Behavioral Biology, McLean Hospital/Harvard Medical School, United States of America
  1. ↵* Corresponding Author:
    Jack Bergman, Behavioral Biology, McLean Hospital/Harvard Medical School, 115 Mill Street Hospital, 115 Mill Street, Belmont, 02178-9106, United States of America. E-mail: jbergman{at}hms.harvard.edu

Statistics from Altmetric.com

Article usage

Article usage: January 2021 to January 2021

AbstractFullPdf
Jan 202157027

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
OtherBehavioral Pharmacology

Varenicline and epibatidine as opioid adjuvants

Fernando Barreto de Moura and Jack Bergman
Journal of Pharmacology and Experimental Therapeutics January 13, 2021, JPET-AR-2020-000423; DOI: https://doi.org/10.1124/jpet.120.000423
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles